Endoscopic central airway recanalization to enable first line pembrolizumab treatment in a PD-L1 strongly positive non-small cell lung cancer: a case report

Peer Review reports

Original Submission
19 Nov 2018	Submitted	Original manuscript
10 Dec 2018	Reviewed	Reviewer Report - Takashi Ohtsuka
17 Dec 2018	Reviewed	Reviewer Report - Federico Quaini
26 Dec 2018	Reviewed	Reviewer Report - Rajesh Sekar
6 Feb 2019	Author responded	Author comments - Alfonso Fiorelli
Resubmission - Version 2
6 Feb 2019	Submitted	Manuscript version 2
Publishing
17 Feb 2019	Editorially accepted
4 Mar 2019	Article published	10.1186/s13019-019-0862-6

Back to article page